Decipher Labs Ltd
DECI

Decipher Labs Ltd (524752)

₹33.791.96%

Key Stats

₹32.05
Day's Price Range
₹34.8
₹27
52-Week Price Range
₹145.7
1 Month Return-27.86 %
3 Month Return-18.35 %
1 Year Return0.75 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 9
2.01
EPS
Rank 109
₹16.47
BVPS
Rank 253
₹23.93
Dividend Yield
Rank 176
ROE
Rank 408
2.2%
Price To Book Ratio
Rank 77
1.38
Debt To Asset
Rank 69
0.64

Company Information

Incorporated as a private limited company in Sep.86 Combat Drugs CDL was converted into a public limited company in Jun.92. The company was promoted by Suchit Mohan Lal and Ajay Karan. CDL came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.94. The proceeds of the issue were utilised to partfinance a Rs 3.25cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables.CDL started commercial production in Jul.87 on a loanlicence basis. The company acquired a fullfledged manufacturing unit located at Balanagar Hyderabad on lease from Fairchild Laboratories and commenced commercial production in Aug.88. In Jul.92 the manufacturing activities were shifted to the present leased premises at Kushaiguda Hyderabad. In this unit various pharmaceutical formulations such as tablets capsules and liquids are being manufactured. The product range of CDL comprises vital antibacterial drugs antibiotic drugs antiinflammatory drugs haematenic drugs and protein tonic. CDL has developed inhouse technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 199596 the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational.During 199697 the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product HB 2 has been well accepted in the market. The company has also filled its application for obtaining the cGMP and WHO GMP Certificate.During the year 199899 the Company initiated steps to diversify into information technology. The Company is in the process of taking over the business of M/s. Softech Institute of Information Technology Software Development which would function as the Infotech Division of the Company. The Company also proposes to change its name to Combat Drugs and Softech Limited so as to justify both the activities of Pharmaceutical Formulations and Information Technology.
OrganisationDecipher Labs Ltd
HeadquartersHyderabad
IndustryPharmaceuticals